nach oben

European Radiology

Erschienen in:

01.03.2012 | Chest

Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria

verfasst von: Andrea Caulo, Saeed Mirsadraee, Fabio Maggi, Lucia Leccisotti, Edwin J. R. van Beek, Lorenzo Bonomo

Erschienen in: European Radiology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To review the role of imaging in the diagnosis of recurrent disease in previously treated non-small cell lung cancer (NSCLC) and discuss the imaging pitfalls.

Methods

A comprehensive review of published literature on CT and PET imaging of NSCLC recurrence was performed. Diagnostic and prognostic values are discussed. Representative imaging examples are illustrated.

Results

Up to 30% of NSCLC recurrences present as loco-regional, involving treated hemithorax and ipsilateral lymph nodes, while 70% present as metachronous distant metastases. CT and PET-CT play an important role in the early detection of recurrence; indications for imaging vary depending on pathological features.

Conclusion

Imaging plays a central role in the identification of recurrence and may predict prognosis.

Key Points

Lung cancer recurs after surgery in 30% to 75% of patients.
CT and PET-CT are crucial in identification of loco-regional recurrence.
Knowledge of potential pitfalls is essential, especially for parenchymal or nodal recurrence.
CT can diagnose metastases but further examinations (PET-CT, MRI) are often needed.
Morphological and functional imaging criteria may help in predicting recurrence.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef

Ferlay J, Shin HR, Bray F (2008) GLOBOCAN Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France International Agency for Research on Cancer. Available at: http://globocan.iarc.fr. Accessed 16/02/2011

Altekruse S, Kosary CL, Krapcho M et al (2010) SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Accessed 3/4/2011

Kanzaki R, Higashiyama M, Maeda J et al (2010) Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Interact Cardiovasc Thorac Surg 10:1009–1014PubMedCrossRef

Bryant A, Cerfolio RJ (2007) Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest 132:185–192PubMedCrossRef

Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717PubMedCrossRef

Van Schil P (2003) The restaging issue. Lung cancer (Amsterdam, Netherlands) 42:S39–S45CrossRef

Bueno R, Richards WG, Swanson SJ et al (2000) Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70:1826–1831PubMedCrossRef

Virgo KS, Johnson FE, Naunheim KS (1999) Follow-up of patients with thoracic malignancies. Surg Oncol Clin N Am 8:355–369PubMed

10.

Rubins J, Unger M, Colice GL (2007) Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest 132:355S–367SPubMedCrossRef

11.

Maeda R, Yoshida J, Hishida T et al (2010) Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up. Chest 138:145–150PubMedCrossRef

12.

Ichinose Y, Kato H, Koike T et al (2001) Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 34:29–36PubMedCrossRef

13.

Moldvay J, Scheid P, Wild P et al (2000) Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res 6:1125–1134PubMed

14.

al-Kattan K, Sepsas E, Fountain SW, Townsend ER (1997) Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 12:380–384PubMedCrossRef

15.

Martini N, Bains MS, Burt ME et al (1995) Incidence of local recurrence and second primary tumours in resected stage I lung cancer. J Thorac Cardiovasc Surg 109:120–129PubMedCrossRef

16.

Crino L, Weder W, van Meerbeeck J, Felip E (2010) Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:v103–v115PubMedCrossRef

17.

Bogot NR, Quint LE (2004) Imaging of recurrent lung cancer. Cancer Imaging 4:61–67PubMedCrossRef

18.

Ponn RB (2000) Lightning can strike twice: second primary lung cancers. Chest 118:1526–1529PubMedCrossRef

19.

Johnson BE (1998) Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 90:1335–1345PubMedCrossRef

20.

Martini N, Melamed MR (1975) Multiple primary lung cancers. J Thorac Cardiovasc Surg 70:606–612PubMed

21.

Seo JB, Im JG, Goo JM, Chung MJ, Kim MY (2001) Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics 21:403–417PubMed

22.

Yano T, Hara N, Ichinose Y et al (1994) Local recurrence after complete resection for non-small-cell carcinoma of the lung. Significance of local control by radiation treatment. J Thorac Cardiovasc Surg 107:8–12PubMed

23.

Hermanek P, Wittekind C (1994) The pathologist and the residual (R) tumour classification. Pathol Res Pract 190:115–123PubMedCrossRef

24.

de Geus-Oei LF, van der Heijden HF, Corstens FH, Oyen WJ (2007) Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review. Cancer 110:1654–1664PubMedCrossRef

25.

Jang KM, Lee KS, Shim YM et al (2003) The rates and CT patterns of locoregional recurrence after resection surgery of lung cancer: correlation with histopathology and tumour staging. J Thorac Imaging 18:225–230PubMedCrossRef

26.

Gaeta M, Blandino A, Pergolizzi S et al (2003) Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study. Lung Cancer 42:319–326PubMedCrossRef

27.

Heyneman LE, Patz EF (2002) PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 38:261–266PubMedCrossRef

28.

Glazer HS, Aronberg DJ, Sagel SS, Emami B (1984) Utility of CT in detecting postpneumonectomy carcinoma recurrence. AJR Am J Roentgenol 142:487–494PubMed

29.

Gorich J, Beyer-Enke SA, Flentje M, Zuna I, Vogt-Moykopf I, Van Kaick G (1990) Evaluation of recurrent bronchogenic carcinoma by computed tomography. Clin Imaging 14:131–137PubMedCrossRef

30.

Hellwig D, Groschel A, Graeter TP et al (2006) Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Eur J Nucl Med Mol Imaging 33:13–21PubMedCrossRef

31.

Chae EJ, Seo JB, Kim SY et al (2006) Radiographic and CT findings of thoracic complications after pneumonectomy. Radiographics 26:1449–1468PubMedCrossRef

32.

Hollaus PH, Wurnig PN, Pridun NS (2003) The natural history of recurrence after bronchoplastic procedures for non-small cell lung cancer. Ann Thorac Surg 76:363–369PubMedCrossRef

33.

Cho A, Hur J, Kang WJ et al (2010) Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction. Eur Radiol 21:1077–1087PubMedCrossRef

34.

Kim SY, Seo JB, Chae EJ et al (2005) Filling defect in a pulmonary arterial stump on CT after pneumonectomy: radiologic and clinical significance. AJR Am J Roentgenol 185:985–988PubMedCrossRef

35.

Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R (2003) The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41:1–11PubMedCrossRef

36.

Videtic GM, Stephans KL (2010) The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep 12:235–241PubMedCrossRef

37.

Trovo M, Linda A, El Naqa I, Javidan-Nejad C, Bradley J (2010) Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 69:77–85PubMedCrossRef

38.

Takeda A, Kunieda E, Takeda T et al (2008) Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumour recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 70:1057–1065PubMedCrossRef

39.

Eradat J, Abtin F, Gutierrez A, Suh R (2011) Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcinoma. Cancer J 17:38–48PubMedCrossRef

40.

Matsuo Y, Nagata Y, Mizowaki T et al (2007) Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumours. Int J Clin Oncol / Jp Soc Clin Oncol 12:356–362CrossRef

41.

Libshitz HI, Sheppard DG (1999) Filling in of radiation therapy-induced bronchiectatic change: a reliable sign of locally recurrent lung cancer. Radiology 210:25–27PubMed

42.

Hadziahmetovic M, Loo BW, Timmerman RD et al (2010) Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer–updates of radiobiology, techniques, and clinical outcomes. Discov Med 9:411–417PubMed

43.

Hoopes DJ, Tann M, Fletcher JW et al (2007) FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 56:229–234PubMedCrossRef

44.

Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T (2002) Clinical applications of radio-frequency tumour ablation in the thorax. Radiographics, 22 Spec No:S259-269

45.

Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE (2010) Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 254:301–307PubMed

46.

Bojarski JD, Dupuy DE, Mayo-Smith WW (2005) CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumours. AJR Am J Roentgenol 185:466–471PubMed

47.

Anderson EM, Lees WR, Gillams AR (2009) Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumours. Cardiovasc Intervent Radiol 32:478–483PubMedCrossRef

48.

Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG (2003) Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation—preliminary results. Radiology 229:821–829PubMedCrossRef

49.

Singnurkar A, Solomon SB, Go M, Larson SM, Scho H (2010) 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions. J Nucl Med 51:1833–1840PubMedCrossRef

50.

Downey RJ (1999) Follow-up of patients with completely resected lung cancer. Chest 115:1487–1488PubMedCrossRef

51.

Vansteenkiste J, Dooms C, De Leyn P (2009) The multidisciplinarity of stage III non-small cell lung cancer. Eur J Cancer 45:92–105PubMedCrossRef

52.

De Leyn P, Lardinois D, Van Schil PE et al (2007) ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32:1–8PubMedCrossRef

53.

Toloza EM, Harpole L, McCrory DC (2003) Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123:137S–146SPubMedCrossRef

54.

Fritscher-Ravens A, Bohuslavizki KH, Brandt L et al (2003) Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest 123:442–451PubMedCrossRef

55.

Yang W, Fu Z, Yu J et al (2008) Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. Lung Cancer 61:35–43PubMedCrossRef

56.

De Leyn P, Vansteenkiste J, Cuypers P et al (1997) Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 12:706–712PubMedCrossRef

57.

Mateu-Navarro M, Rami-Porta R, Bastus-Piulats R, Cirera-Nogueras L, Gonzalez-Pont G (2000) Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann Thorac Surg 70:391–395PubMedCrossRef

58.

Lee KS, Shim YM, Han J et al (2000) Primary tumours and mediastinal lymph nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer: serial CT findings with pathologic correlation. J Comput Assist Tomogr 24:35–40PubMedCrossRef

59.

De Leyn P, Stroobants S, De Wever W et al (2006) Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study. J Clin Oncol 24:3333–3339PubMedCrossRef

60.

Poettgen C, Theegarten D, Eberhardt W et al (2007) Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer. Oncology 73:316–323PubMedCrossRef

61.

Maeda R, Yoshida J, Ishii G et al (2010) Long-term survival and risk factors for recurrence instage I non-small cell lung cancer patients with tumours up to 3 cm in maximum dimension. Chest 138:357–362PubMedCrossRef

62.

Goldstraw P, Crowley J, Chansky K et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2:706–714PubMedCrossRef

63.

Yoshida J, Nagai K, Asamura H et al (2009) Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database. J Thorac Oncol 4:959–963PubMedCrossRef

64.

Hwang JH, Song KS, Park SI, Lim TH, Kwon KH, Goo DE (2005) Subtle pleural metastasis without large effusion in lung cancer patients: preoperative detection on CT. Korean J Radiol 6:94–101PubMedCrossRef

65.

Nakagawa T, Okumura N, Ohata K, Igai H, Matsuoka T, Kameyama K (2008) Postrecurrence survival in patients with stage I non-small cell lung cancer. Eur J Cardiothorac Surg 34:499–504PubMedCrossRef

66.

Yano T, Yokoyama H, Inoue T et al (1994) The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Comparison between pN0 disease and pN2 disease. J Thorac Cardiovasc Surg 108:680–683PubMed

67.

De Wever W, Ceyssens S, Mortelmans L et al (2007) Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol 17:23–32PubMedCrossRef

68.

De Wever W, Vankan Y, Stroobants S, Verschakelen J (2007) Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J 29:995–1002PubMedCrossRef

69.

Vansteenkiste JF (2002) Imaging in lung cancer: positron emission tomography scan. Eur Respir J 35:49s–60sCrossRef

70.

Takenaka D, Ohno Y, Koyama H et al (2010) Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients. Eur J Radiol 74:458–464PubMedCrossRef

71.

Onishi Y, Ohno Y, Koyama H et al (2010) Non-small cell carcinoma: Comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations. Eur J Radiol doi:10.1016/j.ejrad.2010.04.027

72.

Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA (2007) Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:202S–220SPubMedCrossRef

73.

Revel MP, Merlin A, Peyrard S et al (2006) Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules. AJR Am J Roentgenol 187:135–142PubMedCrossRef

74.

Hishida T, Nagai K, Yoshida J et al (2006) Is surgical resection indicated for a solitary non-small cell lung cancer recurrence? J Thorac Cardiovasc Surg 131:838–842PubMedCrossRef

75.

Swensen SJ, Viggiano RW, Midthun DE et al (2000) Lung nodule enhancement at CT: multicenter study. Radiology 214:73–80PubMed

76.

Girvin F, Ko JP (2008) Pulmonary nodules: detection, assessment, and CAD. AJR Am J Roentgenol 191:1057–1069PubMedCrossRef

77.

Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G (2009) PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol 70:382–392PubMedCrossRef

78.

Yokoi K, Kamiya N, Matsuguma H et al (1999) Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest 115:714–719PubMedCrossRef

79.

Marom EM, McAdams HP, Erasmus JJ et al (1999) Staging non-small cell lung cancer with whole-body PET. Radiology 212:803–809PubMed

80.

Lee HY, Lee KS, Kim BT et al (2009) Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma. J Korean Med Sci 24:1132–1138PubMedCrossRef

81.

Munden RF, Swisher SS, Stevens CW, Stewart DJ (2005) Imaging of the patient with non-small cell lung cancer. Radiology 237:803–818PubMedCrossRef

82.

Mayo-Smith WW, Boland GW, Noto RB, Lee MJ (2001) State-of-the-art adrenal imaging. Radiographics 21:995–1012PubMed

83.

Blake MA, Slattery JM, Kalra MK et al (2006) Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy–initial experience. Radiology 238:970–977PubMedCrossRef

84.

Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E (2006) 18-F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47:32–37PubMed

85.

Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK (2009) Adrenal nodules at FDG PET / CT in patients known to have or suspected of having lung cancer. A proposal for an efficient diagnostic algorithm. Radiology 250:523–530PubMedCrossRef

86.

Takeda S, Fukai S, Komatsu H, Nemoto E, Nakamura K, Murakami M (2005) Impact of large tumour size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Ann Thorac Surg 79:1142–1146PubMedCrossRef

87.

Kamiyoshihara M, Kawashima O, Sakata S, Hirai T, Ishikawa S, Morishita Y (1999) Does an incomplete interlobar fissure influence survival or recurrence in resected non-small-cell lung cancer? Lung cancer (Amsterdam, Netherlands) 25:33–38CrossRef

88.

Nair VS, Barnett PG, Ananth L, Gould MK (2010) PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest 137:1150–1156PubMedCrossRef

89.

Higashi K, Ueda Y, Arisaka Y et al (2002) 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 43:39–45PubMed

90.

Moretti L, Yu DS, Chen H et al (2009) Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy. Oncologist 14:1106–1115PubMedCrossRef

Titel: Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria
verfasst von: Andrea Caulo
Saeed Mirsadraee
Fabio Maggi
Lucia Leccisotti
Edwin J. R. van Beek
Lorenzo Bonomo
Publikationsdatum: 01.03.2012
Verlag: Springer-Verlag
Erschienen in: European Radiology / Ausgabe 3/2012
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-011-2299-8

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Obesity-related juvenile form of cartilage lesions: a new affliction in the knees of morbidly obese children and adolescents

One-to-one comparison between digital spot compression view and digital breast tomosynthesis

Integrative role of MRI in the evaluation of primary biliary cirrhosis

Diagnostic performance of 64-section CT using CT gastrography in preoperative T staging of gastric cancer according to 7th edition of AJCC cancer staging manual

Percutaneous removal of sentinel lymph nodes in a swine model using a breast lesion excision system and contrast-enhanced ultrasound

MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie